Immunobiologists in China have designed a synthetic T-cell receptor for anticancer therapy, engineering the protein with great endurance in its mission to destroy solid tumours, reports Medical Xpress. The research has been conducted in animal models only, but it is a step toward a new form of therapy for solid tumours. The current treatment is composed of specially endowed cells that are engineered to destroy cancers of the blood. The emerging form promises the same action – killing cancer cells – but this time from solid tumours while leaving healthy tissue unscathed.
https://medicalxpress.com/news/2021-04-global-cell-receptor-zeros-onand.html
